T1	Multiplier 6 15	half-dose
T2	Drug 16 26	ticagrelor
T3	Measurement 28 40	loading dose
T4	Value 41 45	90mg
T5	Multiplier 56 67	45mg bidpo.
R1	Has_value Arg1:T3 Arg2:T4	
T6	Scope 28 67	loading dose 90mg, and then 45mg bidpo.
R2	Subsumes Arg1:T1 Arg2:T6	
R3	Has_multiplier Arg1:T2 Arg2:T1	
T7	Temporal 69 89	treatment for 3 days
R4	Has_temporal Arg1:T2 Arg2:T7	
T8	Measurement 95 115	platelet aggregation
T9	Value 131 140	inhibited
R5	Has_value Arg1:T8 Arg2:T9	
T10	Qualifier 119 130	effectively
R6	Has_qualifier Arg1:T9 Arg2:T10	
T11	Procedure 144 175	light transmission aggregometry
T12	Procedure 187 205	thromboela-stogram
T13	Scope 144 205	light transmission aggregometry method and thromboela-stogram
R7	Has_scope Arg1:T8 Arg2:T13	
T14	Mood 208 226	planned to undergo
T15	Procedure 227 230	PCI
T16	Temporal 231 239	recently
R8	Has_mood Arg1:T15 Arg2:T14	
T17	Scope 208 230	planned to undergo PCI
R9	Has_temporal Arg1:T17 Arg2:T16	
T18	Mood 241 251	planned to
T19	Procedure 252 256	DAPT
T20	Multiplier 257 267	for 1 year
T21	Temporal 268 277	after PCI
T22	Procedure 274 277	PCI
T23	Reference_point 274 277	PCI
R10	Has_index Arg1:T21 Arg2:T23	
R11	multi Arg1:T23 Arg2:T22	
R12	Has_multiplier Arg1:T19 Arg2:T20	
R13	Has_temporal Arg1:T19 Arg2:T21	
R14	Has_mood Arg1:T19 Arg2:T18	
